Lazard Capital says this weekend's New York Times article on Questcor raises no new issues, but notes the report slants negative. The firm believes that while the article raises the profile of the high price of Acthar, it adds little to the debate surrounding shares of Questcor. Lazard Capital has a Buy rating on the stock with a $74 price target.
Happy demi-anniversary, stock market rally. Will the honeymoon ever end?